Rev Esp Quimioter 2015:28(Suppl. 1):52-53
Optimization strategies in management of CMV infection in transplant patients DAVID NAVARRO Currently, two therapeutic strategies are applied for preventing the development of CMV end-organ disease in transplant recipients: universal prophylaxis and preemptive antiviral therapy. Both are potentially optimable. As for the former strategy, precisely identifying patients at greatest risk of viremia would allow […]
